Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
McKinsey
Dow
AstraZeneca
Express Scripts

Last Updated: May 24, 2022

ELYXYB Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Elyxyb, and what generic alternatives are available?

Elyxyb is a drug marketed by Bdsi and is included in one NDA. There are six patents protecting this drug.

This drug has twenty-four patent family members in twelve countries.

The generic ingredient in ELYXYB is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the celecoxib profile page.

US Patents and Regulatory Information for ELYXYB

ELYXYB is protected by six US patents and one FDA Regulatory Exclusivity.

Patents protecting ELYXYB

Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

Oral composition of celecoxib for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE WITH OR WITHOUT AURA IN ADULTS

FDA Regulatory Exclusivity protecting ELYXYB

NEW PRODUCT
Exclusivity Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Bdsi ELYXYB celecoxib SOLUTION;ORAL 212157-001 May 5, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ELYXYB

See the table below for patents covering ELYXYB around the world.

Country Patent Number Title Estimated Expiration
Brazil 112018074486 composição oral de celecoxib para tratamento da dor See Plans and Pricing
China 109496151 用于治疗疼痛的塞来昔布口服组合物 (ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN) See Plans and Pricing
European Patent Office 3302429 See Plans and Pricing
China 107847437 See Plans and Pricing
South Korea 101994129 See Plans and Pricing
New Zealand 737561 Oral composition of celecoxib for treatment of pain See Plans and Pricing
Russian Federation 2708254 Пероральная композиция целекоксиба для лечения боли (ORAL CELECOXIB COMPOSITION FOR TREATING PAIN) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ELYXYB

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0731795 10075033 Germany See Plans and Pricing PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Boehringer Ingelheim
Medtronic
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.